Indication
Intractable
1 clinical trial
2 products
Product
ResiniferatoxinClinical trial
A Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced CancerStatus: , Estimated PCD: 2027-06-01
Product
Placebo